TAP Blocks vs. IV Lidocaine for Kidney Transplants



Status:Not yet recruiting
Conditions:Post-Surgical Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:2/20/2019
Start Date:March 1, 2019
End Date:September 1, 2021
Contact:Neil A Hanson, MD
Email:neil.hanson@virginiamason.org
Phone:206-223-6980

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Comparison of Transversus Abdominis Plane Blocks Versus Continuous Intravenous Lidocaine for Kidney Transplant Surgery

This study will compare continuous intravenous lidocaine against single-injection transversus
abdominis plane (TAP) block as a modality for postoperative analgesia in kidney transplant
surgery.

This study is a non-inferiority trial designed to assess the analgesic efficacy of an
intravenous (IV) lidocaine infusion against single-injection transversus abdominis plane
(TAP) block in patients undergoing kidney transplant surgery. The investigators propose a
study of 124 subjects randomized into two groups. The control group will receive a TAP block.
The study group will receive a continuous IV lidocaine infusion. The investigators
hypothesize that there will be no statistically significant difference in postoperative
opioid consumption between the two groups in the first 24 hours.

Inclusion Criteria:

- Kidney transplant recipient

- >18 years old

- Consent to participate

Exclusion Criteria:

- <18 years old

- Refusal to participate

- Chronic opioid use

- Seizure disorder

- Allergy to local anesthestics

- Severe hepatic disease
We found this trial at
1
site
Virginia Mason Medical Center
Seattle, Washington 98101
(888) 862-2737
Virginia Mason Medical Center Established in 1920, Virginia Mason began as an 80-bed hospital with...
?
mi
from
Seattle, WA
Click here to add this to my saved trials